256 related articles for article (PubMed ID: 15001791)
21. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
22. Activation of estrogen receptor-α and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats.
Shimada K; Kitazato KT; Kinouchi T; Yagi K; Tada Y; Satomi J; Kageji T; Nagahiro S
Hypertension; 2011 Jun; 57(6):1161-6. PubMed ID: 21536991
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
[TBL] [Abstract][Full Text] [Related]
24. Constrictor and dilator effects of angiotensin II on cerebral arterioles.
Vincent JM; Kwan YW; Chan SL; Perrin-Sarrado C; Atkinson J; Chillon JM
Stroke; 2005 Dec; 36(12):2691-5. PubMed ID: 16269635
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor.
Wang W; Ma X; Han J; Zhou M; Ren H; Pan Q; Zheng C; Zheng Q
PLoS One; 2016; 11(1):e0146197. PubMed ID: 26730961
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.
Shinozaki K; Ayajiki K; Nishio Y; Sugaya T; Kashiwagi A; Okamura T
Hypertension; 2004 Feb; 43(2):255-62. PubMed ID: 14698997
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.
Lu Q; Zhu YZ; Wong PT
Neuroreport; 2005 Nov; 16(17):1963-7. PubMed ID: 16272888
[TBL] [Abstract][Full Text] [Related]
29. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
Zwart AS; Davis EA; Widdop RE
Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.
Faure S; Bureau A; Oudart N; Javellaud J; Fournier A; Achard JM
J Hypertens; 2008 Oct; 26(10):2008-15. PubMed ID: 18806625
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding.
Hiyoshi H; Yayama K; Takano M; Okamoto H
Hypertension; 2004 Jun; 43(6):1258-63. PubMed ID: 15123575
[TBL] [Abstract][Full Text] [Related]
32. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats.
Ando H; Zhou J; Macova M; Imboden H; Saavedra JM
Stroke; 2004 Jul; 35(7):1726-31. PubMed ID: 15143297
[TBL] [Abstract][Full Text] [Related]
34. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.
Makino N; Hata T; Sugano M; Dixon IM; Yanaga T
J Mol Cell Cardiol; 1996 Mar; 28(3):507-17. PubMed ID: 9011634
[TBL] [Abstract][Full Text] [Related]
35. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat.
Lou M; Blume A; Zhao Y; Gohlke P; Deuschl G; Herdegen T; Culman J
J Cereb Blood Flow Metab; 2004 May; 24(5):536-47. PubMed ID: 15129186
[TBL] [Abstract][Full Text] [Related]
36. The angiotensin II receptor type 1b is the primary sensor of intraluminal pressure in cerebral artery smooth muscle cells.
Pires PW; Ko EA; Pritchard HAT; Rudokas M; Yamasaki E; Earley S
J Physiol; 2017 Jul; 595(14):4735-4753. PubMed ID: 28475214
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells.
Liu HQ; Wei XB; Sun R; Cai YW; Lou HY; Wang JW; Chen AF; Zhang XM
Life Sci; 2006 Feb; 78(12):1293-8. PubMed ID: 16343550
[TBL] [Abstract][Full Text] [Related]
38. Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts.
Jiang X; Zhang F; Ning Q
Pathol Biol (Paris); 2015 Jun; 63(3):122-5. PubMed ID: 25979571
[TBL] [Abstract][Full Text] [Related]
39. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
Yayama K; Sugiyama K; Miyagi R; Okamoto H
Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
